The Concise Guide to PHARMACOLOGY 2015/16: Overview

The Concise Guide to PHARMACOLOGY 2015/16 provides concise overviews of the key properties of over 1750 human drug targets with their pharmacology, plus links to an open access knowledgebase of drug targets and their ligands ( www.guidetopharmacology.org ), which provides more detailed views of target and ligand properties. The full contents can be found at http://onlinelibrary.wiley.com/doi/10.1111/bph.13347/full . This compilation of the major pharmacological targets is divided into eight areas of focus: G protein‐coupled receptors, ligand‐gated ion channels, voltage‐gated ion channels, other ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The Concise Guide is published in landscape format in order to facilitate comparison of related targets. It is a condensed version of material contemporary to late 2015, which is presented in greater detail and constantly updated on the website www.guidetopharmacology.org , superseding data presented in the previous Guides to Receptors & Channels and the Concise Guide to PHARMACOLOGY 2013/14. It is produced in conjunction with NC‐IUPHAR and provides the official IUPHAR classification and nomenclature for human drug targets, where appropriate. It consolidates information previously curated and displayed separately in IUPHAR‐DB and GRAC and provides a permanent, citable, point‐in‐time record that will survive database updates.

[1]  J. Storch,et al.  Tissue-specific Functions in the Fatty Acid-binding Protein Family* , 2010, The Journal of Biological Chemistry.

[2]  C. Poüs,et al.  The ins and outs of tubulin acetylation: more than just a post-translational modification? , 2011, Cellular signalling.

[3]  M. Rasenick,et al.  Tubulin, actin and heterotrimeric G proteins: coordination of signaling and structure. , 2014, Biochimica et biophysica acta.

[4]  宁北芳,et al.  疟原虫var基因转换速率变化导致抗原变异[英]/Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .

[5]  P. Scherer,et al.  Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies. , 2009, Trends in pharmacological sciences.

[6]  Yitao Wang,et al.  Adiponectin, an unlocking adipocytokine. , 2009, Cardiovascular therapeutics.

[7]  닐스 론버그,et al.  Human ctla-4 antibodies and their uses , 2000 .

[8]  A. Beck‐Sickinger,et al.  Molecular tools to characterize adiponectin activity. , 2012, Vitamins and hormones.

[9]  M. Record,et al.  Importance of cholesterol and oxysterols metabolism in the pharmacology of tamoxifen and other AEBS ligands. , 2011, Chemistry and physics of lipids.

[10]  B. Dubrovsky Neurosteroids, neuroactive steroids, and symptoms of affective disorders , 2006, Pharmacology Biochemistry and Behavior.

[11]  M. Fasshauer,et al.  Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease? , 2012, Diabetologia.

[12]  A. Chmurzyńska The multigene family of fatty acid-binding proteins (FABPs): Function, structure and polymorphism , 2010, Journal of Applied Genetics.

[13]  Xinliang Ma,et al.  Protective vascular and myocardial effects of adiponectin , 2009, Nature Clinical Practice Cardiovascular Medicine.

[14]  그람헤르만,et al.  Antibodies to human IL-1β , 2001 .

[15]  C. Mantzoros,et al.  The role of adiponectin in cancer: a review of current evidence. , 2012, Endocrine reviews.

[16]  X. Codony,et al.  Sigma receptors: biology and therapeutic potential , 2004, Psychopharmacology.

[17]  T. Matsuo,et al.  Classification of FABP isoforms and tissues based on quantitative evaluation of transcript levels of these isoforms in various rat tissues , 2009, Biotechnology Letters.

[18]  Megan Lerner,et al.  σ Receptors: potential medications development target for anti-cocaine agents , 2003 .

[19]  ザルフェルト,ヨッヘン,ゲー.,et al.  Human antibodies that bind to human TNFα , 1997 .

[20]  C. Buechler,et al.  Adiponectin receptor binding proteins – recent advances in elucidating adiponectin signalling pathways , 2010, FEBS letters.

[21]  H. R. Payne,et al.  Role of Fatty Acid Binding Proteins and Long Chain Fatty Acids in Modulating Nuclear Receptors and Gene Transcription , 2007, Lipids.

[22]  M. Furuhashi,et al.  Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets , 2008, Nature Reviews Drug Discovery.

[23]  Yan Lu,et al.  An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site , 2012, Pharmaceutical Research.

[24]  陈刚,et al.  IL-1β binding antibodies and fragments , 2006 .

[25]  Gurneet Kaur,et al.  Recent developments in tubulin polymerization inhibitors: An overview. , 2014, European journal of medicinal chemistry.

[26]  T. Arumugam,et al.  Adiponectin receptor signalling in the brain , 2012, British journal of pharmacology.